blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3204012

EP3204012 - CORTEXOLONE 17ALPHA-BENZOATE FOR USE IN THE TREATMENT OF TUMOURS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.04.2021
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  01.05.2020
FormerGrant of patent is intended
Status updated on  01.01.2020
FormerRequest for examination was made
Status updated on  14.07.2017
FormerThe international publication has been made
Status updated on  26.04.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Cosmo Technologies Ltd
Riverside II
Sir John Rogerson's Quay
Dublin 2 / IE
[2017/33]
Inventor(s)01 / GERLONI, Mara
2933 Ariane Drive
San Diego, California 2117 / US
 [2017/33]
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2020/23]FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Former [2017/33]Hally, Anna-Louise
FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Application number, filing date15775455.707.10.2015
[2017/33]
WO2015EP73176
Priority number, dateEP2014018806308.10.2014         Original published format: EP 14188063
[2017/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016055537
Date:14.04.2016
Language:EN
[2016/15]
Type: A1 Application with search report 
No.:EP3204012
Date:16.08.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2016 takes the place of the publication of the European patent application.
[2017/33]
Type: B1 Patent specification 
No.:EP3204012
Date:03.06.2020
Language:EN
[2020/23]
Search report(s)International search report - published on:EP14.04.2016
ClassificationIPC:A61K31/573, A61P35/00
[2017/33]
CPC:
A61K31/573 (EP,CN,IL,KR,US); C07J5/0053 (EP,CN,IL,KR,US); A61K45/06 (IL,US);
A61K9/0019 (IL,US); A61K9/0053 (IL,US); A61P35/00 (EP,KR);
A61P35/04 (EP,KR); A61P43/00 (EP); A61P5/46 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/33]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:CORTEXOLON-17ALPHA-BENZOAT VERWENDUNG BEI DER BEHANDLUNG VON TUMOREN[2020/01]
English:CORTEXOLONE 17ALPHA-BENZOATE FOR USE IN THE TREATMENT OF TUMOURS[2017/33]
French:CORTEXOLONE-17ALPHA-BENZOATE POUR UTILISATION DANS LE TRAITEMENT DE TUMEURS[2020/01]
Former [2017/33]CORTEXOLON-17ALPHA-BENZOAT ZUR VERWENDUNG IN DER BEHANDLUNG VON TUMOREN
Former [2017/33]17-ALPHA-BENZOATE DE CORTEXOLONE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE TUMEURS
Entry into regional phase26.04.2017National basic fee paid 
26.04.2017Designation fee(s) paid 
26.04.2017Examination fee paid 
Examination procedure26.04.2017Examination requested  [2017/33]
26.04.2017Date on which the examining division has become responsible
01.12.2017Amendment by applicant (claims and/or description)
02.01.2020Communication of intention to grant the patent
23.04.2020Fee for grant paid
23.04.2020Fee for publishing/printing paid
23.04.2020Receipt of the translation of the claim(s)
Opposition(s)04.03.2021No opposition filed within time limit [2021/19]
Fees paidRenewal fee
31.07.2017Renewal fee patent year 03
26.10.2018Renewal fee patent year 04
22.10.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.10.2015
AL03.06.2020
AT03.06.2020
CY03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
MK03.06.2020
MT03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
TR03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
IE07.10.2020
LU07.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
[2022/32]
Former [2022/27]HU07.10.2015
AL03.06.2020
AT03.06.2020
CY03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
MT03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
TR03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
IE07.10.2020
LU07.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/46]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
IE07.10.2020
LU07.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/37]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
LU07.10.2020
BE31.10.2020
CH31.10.2020
LI31.10.2020
Former [2021/36]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
LU07.10.2020
BE31.10.2020
Former [2021/31]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
LU07.10.2020
Former [2021/24]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
Former [2021/21]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
Former [2021/10]AL03.06.2020
AT03.06.2020
CZ03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
PL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
PT06.10.2020
Former [2021/09]AL03.06.2020
AT03.06.2020
CZ03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
PT06.10.2020
Former [2021/04]AL03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RS03.06.2020
SE03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
Former [2021/01]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RS03.06.2020
SE03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
Former [2020/51]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RS03.06.2020
SE03.06.2020
NO03.09.2020
GR04.09.2020
Former [2020/50]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
SE03.06.2020
NO03.09.2020
GR04.09.2020
Former [2020/48]FI03.06.2020
LT03.06.2020
SE03.06.2020
NO03.09.2020
Former [2020/47]LT03.06.2020
NO03.09.2020
Cited inInternational search[A]US3530038  (FLINES JAN DE, et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.